Stocks
Funds
Screener
Sectors
Watchlists
TELA

TELA - Tela Bio Inc Stock Price, Fair Value and News

$2.79-0.01 (-0.36%)
Delayed as of 06 Feb 2025, 01:28 pm ET
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

TELA Price Action

Last 7 days

1.1%


Last 30 days

-1.4%


Last 90 days

-6.3%


Trailing 12 Months

-59.3%

TELA RSI Chart

TELA Valuation

Market Cap

110.3M

Price/Earnings (Trailing)

-2.66

Price/Sales (Trailing)

1.61

Price/Free Cashflow

-2.4

TELA Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

TELA Fundamentals

TELA Revenue

Revenue (TTM)

68.6M

Rev. Growth (Yr)

25.94%

Rev. Growth (Qtr)

17.81%

TELA Earnings

Earnings (TTM)

-41.5M

Earnings Growth (Yr)

5.34%

Earnings Growth (Qtr)

17.68%

TELA Profitability

Return on Equity

662.04%

Return on Assets

-78.32%

Free Cashflow Yield

-41.75%

TELA Investor Care

Shares Dilution (1Y)

60.84%

Diluted EPS (TTM)

-1.67

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202463.1M64.7M68.6M0
202345.1M49.2M53.1M58.5M
202231.8M34.7M38.2M41.4M
202120.4M24.4M26.8M29.5M
202015.9M16.1M17.4M18.2M
201910.1M11.9M13.7M15.4M
2018006.3M8.3M
20170004.2M
TELA
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
 CEO
 WEBSITEtelabio.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES173

Tela Bio Inc Frequently Asked Questions


What is the ticker symbol for Tela Bio Inc? What does TELA stand for in stocks?

TELA is the stock ticker symbol of Tela Bio Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Tela Bio Inc (TELA)?

As of Wed Feb 05 2025, market cap of Tela Bio Inc is 110.29 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TELA stock?

You can check TELA's fair value in chart for subscribers.

Is Tela Bio Inc a good stock to buy?

The fair value guage provides a quick view whether TELA is over valued or under valued. Whether Tela Bio Inc is cheap or expensive depends on the assumptions which impact Tela Bio Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TELA.

What is Tela Bio Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Feb 05 2025, TELA's PE ratio (Price to Earnings) is -2.66 and Price to Sales (PS) ratio is 1.61. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TELA PE ratio will change depending on the future growth rate expectations of investors.